Usefulness of ramosetron hydrochloride on nausea and vomiting in CMF or CEF therapy for breast cancer

Gan to kagaku ryoho. Cancer & chemotherapy

Volumn 26, Issue 8, 1999, Pages 1163-1170

  Taguchi, T ^a   Tsukamoto, F ^a   Watanabe, T ^a   Yoneda, K ^a   Takamura, Y ^a   Hojo, S ^a   Shiba, E ^a   Noguchi, S ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; ANTINEOPLASTIC ANTIMETABOLITE; BENZIMIDAZOLE DERIVATIVE; CISPLATIN; CMF PROTOCOL; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; RAMOSETRON; SEROTONIN ANTAGONIST;

ADULT; AGED; APPETITE; ARTICLE; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DRUG EFFECT; FEMALE; HUMAN; MALE; MIDDLE AGED; NAUSEA; SAFETY; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APPETITE; BENZIMIDAZOLES; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CISPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; FEMALE; FLUOROURACIL; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; NAUSEA; SAFETY; SEROTONIN ANTAGONISTS; TREATMENT OUTCOME; VOMITING;

EID: 0033158587     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)